Literature DB >> 10663560

Localization of Idd11 using NOD congenic mouse strains: elimination of Slc9a1 as a candidate gene.

T C Brodnicki1, P McClive, S Couper, G Morahan.   

Abstract

Type 1 diabetes is a multigenic autoimmune disease, the genetic basis for which is perhaps best characterized in the nonobese diabetic (NOD) mouse model. We previously located a NOD diabetes susceptibility locus, designated Idd11, on mouse Chromosome (Chr) 4 by analyzing diabetic backcross mice produced after crossing NOD/Lt with the nondiabetic resistant strain C57BL/6 (B6) strain. In order to confirm Idd11 and further refine its location, three NOD congenic mouse strains with different B6 derived intervals within Chr 4 were generated. Two of the congenic strains had a significant decrease in the cumulative incidence of diabetes compared with NOD/Lt control mice. The third NOD congenic strain, containing a B6 interval surrounding the Slc9a1 locus, was not protected against diabetes. These results define a new distal boundary for Idd11 and eliminate the Slc9a1 gene as a candidate. The Idd11 locus has now been definitively mapped to a 13cM interval on mouse Chr 4.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10663560     DOI: 10.1007/s002510050006

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  11 in total

Review 1.  Comparative genetics: synergizing human and NOD mouse studies for identifying genetic causation of type 1 diabetes.

Authors:  John P Driver; Yi-Guang Chen; Clayton E Mathews
Journal:  Rev Diabet Stud       Date:  2012-12-28

2.  A recombination hotspot leads to sequence variability within a novel gene (AK005651) and contributes to type 1 diabetes susceptibility.

Authors:  Iris K L Tan; Leanne Mackin; Nancy Wang; Anthony T Papenfuss; Colleen M Elso; Michelle P Ashton; Fiona Quirk; Belinda Phipson; Melanie Bahlo; Terence P Speed; Gordon K Smyth; Grant Morahan; Thomas C Brodnicki
Journal:  Genome Res       Date:  2010-11-04       Impact factor: 9.043

Review 3.  Nonobese diabetic mice and the genetics of diabetes susceptibility.

Authors:  Edward H Leiter
Journal:  Curr Diab Rep       Date:  2005-04       Impact factor: 4.810

Review 4.  Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.

Authors:  John P Driver; David V Serreze; Yi-Guang Chen
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

Review 5.  Mind the gap: analysis of marker-assisted breeding strategies for inbred mouse strains.

Authors:  Nicola J Armstrong; Thomas C Brodnicki; Terence P Speed
Journal:  Mamm Genome       Date:  2006-04-04       Impact factor: 2.957

6.  Loss of T cell progenitor checkpoint control underlies leukemia initiation in Rag1-deficient nonobese diabetic mice.

Authors:  Mary A Yui; Ni Feng; Jingli A Zhang; Chen Yee Liaw; Ellen V Rothenberg; Jeffrey A Longmate
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

Review 7.  Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice.

Authors:  Y Yang; P Santamaria
Journal:  Diabetologia       Date:  2003-10-28       Impact factor: 10.122

8.  Genetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and Polymorphisms.

Authors:  Peng Gao; Yan Jiao; Qing Xiong; Cong-Yi Wang; Ivan Gerling; Weikuan Gu
Journal:  Curr Genomics       Date:  2008       Impact factor: 2.236

9.  The stretcher spontaneous neurodegenerative mutation models Charcot-Marie-Tooth disease type 4D.

Authors:  David Chandler; Sash Lopaticki; Dexing Huang; Michael Hunter; Dora Angelicheva; Trevor Kilpatrick; Rosalind Hm King; Luba Kalaydjieva; Grant Morahan
Journal:  F1000Res       Date:  2013-02-13

10.  Idd9.1 locus controls the suppressive activity of FoxP3+CD4+CD25+ regulatory T-cells.

Authors:  Jun Yamanouchi; Maria-Carmen Puertas; Joan Verdaguer; Paul A Lyons; Daniel B Rainbow; Giselle Chamberlain; Kara M Hunter; Laurence B Peterson; Linda S Wicker; Pere Santamaria
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.